CD32A (Fc gamma RIIa) mRNA expression and regulation in blood monocytes and cell lines
Y G Alevy1, J Tucker, T Mohanakumar
1Department of Surgery, Washington University School of Medicine, St Louis, MO 63110.
Insights
Phorbol ester (PMA), aggregated IgG, and anti-CD32 antibodies significantly increase CD32A mRNA levels in immune cells. This upregulation is transcriptionally regulated and affects both cell lines and primary monocytes.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- CD32 receptors (Fc gamma RII) bind immunoglobulin G (IgG) and are crucial for immune responses.
- Cell surface expression of CD32 is tightly regulated by various agents.
Purpose of the Study:
- To investigate the regulatory effects of phorbol ester (PMA), aggregated IgG (AIgG), and anti-CD32 monoclonal antibodies (mAb) on CD32A isomer mRNA expression.
- To elucidate the mechanisms underlying CD32A mRNA regulation, including transcriptional and post-transcriptional control.
Main Methods:
- Incubation of CD32+ cell lines (U937, K562) and primary human monocytes with PMA, AIgG, or anti-CD32 mAb.
- Treatment with actinomycin D (ActD) to assess transcriptional regulation.
- Inhibition of protein synthesis to evaluate its role in upregulation.
Main Results:
- PMA significantly enhances CD32A mRNA in U937 cells.
- AIgG and anti-CD32 mAb markedly enhance CD32A mRNA in K562 cells.
- ActD treatment blocks the enhancement, indicating transcriptional regulation.
- PMA-induced mRNA is rapidly degraded, unlike constitutively expressed mRNA.
- Upregulation occurs in both cell lines and primary blood monocytes, independent of protein synthesis.
Conclusions:
- CD32A mRNA expression is transcriptionally upregulated by PMA, AIgG, and anti-CD32 mAb.
- Differential mRNA stability suggests distinct regulatory pathways for stimulated versus unstimulated CD32A.
- These findings are relevant to immune cell activation and regulation.
Abstract:
The cell surface expression of the CD32 receptors for the Fc portion of immunoglobulin G (Fc gamma RII) is highly regulated by agents such as phorbol ester (PMA) and cytokines. In this study we investigated the regulatory effects of PMA, aggregated IgG (AIgG) and KuFc79 anti-CD32 monoclonal antibodies (mAb) on the expression of the CD32A isomer mRNA. When U937 (CD32+ cells) are incubated with PMA a significant enhancement of the CD32A isomer mRNA is observed. The CD32A mRNA is also markedly enhanced when the CD32+ K562 cells are incubated with AIgG and anti-CD32 mAb but not with control MOPC-195 mAb. The addition of actinomycin D (ActD), a transcriptional inhibitor together with PMA, AIgG or KuFc79 mAb diminishes the enhanced levels of CD32A mRNA to the basal, constitutively expressed levels, implicating transcriptional regulation in this modulatory process. The PMA induced mRNA is rapidly degraded while the constitutively expressed CD32A mRNA is not, suggesting differential regulation of the stimulated vs the unstimulated CD32A mRNA. Inhibition of protein synthesis does not significantly affect the upregulation of CD32 mRNA by PMA, AIgG or KuFc79 in U937 and K562 cells. The upregulation of CD32A mRNA observed in the cell lines U937 and K562 is also detected when normal blood monocytes are used. Similarly to the cell lines the enhancement of CD32A mRNA in monocytes is blocked by ActD.
